| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0089 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |